NMS · —

Autolus Therapeutics plc (AUTL) Stock

$1.46 -13.61% NMS: AUTL —

—

Valuation

MetricValue
Price$1.46
Market Cap—
P/E Ratio-1.35
P/B Ratio—
P/S Ratio—
EPS (TTM)$-1.08
52-Week High$2.70
52-Week Low$1.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-161.80%
ROA-48.90%
ROCE-52.52%
Gross Margin-361.33%
Operating Margin-361.33%
Net Margin-384.00%
Debt/Equity0.00
Current Ratio5.97

Annual Financials (USD)

Metric20212022202320242025
Revenue——$2.0M$10.0M$75.0M
Operating Profit$-141.0M$-143.0M$-180.0M$-241.0M$-271.0M
Net Profit$-142.0M$-149.0M$-208.0M$-221.0M$-288.0M
EPS$-1.97$-1.57$-1.20$-0.86$-1.08
Op Margin——-10583.0%-2386.0%-359.0%

Balance Sheet (USD)

Metric20222022202320242025
Total Assets$364.0M$364.0M$375.0M$783.0M$589.0M
Total Liabilities$93.0M$93.0M$264.0M$355.0M$411.0M
Cash$269.0M$269.0M$240.0M$227.0M$104.0M
Borrowings—————

Latest News

Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees Insider Monkey · Jul 14, 2026 European Equities Traded in the US as American Depositary Receipts Decline Friday MT Newswires · Jul 10, 2026 European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading MT Newswires · Jul 8, 2026 European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading MT Newswires · Jul 7, 2026 European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading MT Newswires · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-118.0M$-112.0M$-146.0M$-206.0M$-284.0M
Investing Cash Flow$-9.0M$-11.0M$-11.0M$-395.0M$158.0M
Financing Cash Flow$284.0M$224.0M$-1.0M$590.0M$-4.0M
Net Cash Flow$157.0M$100.0M$-157.0M$-11.0M$-129.0M
Free Cash Flow$-127.0M$-123.0M$-157.0M$-228.0M$-303.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio5.52
Interest Coverage-7.32
Return 1Y-40.16%
Return 3Y-41.60%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADCTADC Therapeutics S.A. $1.19 +3.48% -1.09 $151.36M 0.00%
ANNX $5.37 +0.75% -3.71 $879.83M 0.00%
AURA $7.06 -1.40% -4.35 $453.25M 0.00%
BNTC $13.07 -0.46% -11.78 $449.01M 0.00%
LBRX $48.11 -0.15% -29.66 $1.38B 0.00%

About Autolus Therapeutics plc

—

the stock is valued at a price-to-earnings (P/E) ratio of -1.35. Over the past 52 weeks the stock has ranged between $1.18 and $2.70, and currently trades 45.9% below its 52-week high.

On profitability, Autolus Therapeutics plc generates a return on equity (ROE) of -161.80%, return on capital employed of -52.52%, an operating margin of -361.33%, a net profit margin of -384.00%.

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides